ECCO Topical Review: Refractory Inflammatory Bowel Disease

Raine T, Verstockt B, Kopylov U, Karmiris K, Goldberg R, Atreya R, Burisch J, Burke J, Ellul P, Hedin C, Holubar SD, Katsanos K, Lobaton T, Schmidt C, Cullen G (2021)


Publication Type: Journal article, Review article

Publication year: 2021

Journal

Book Volume: 15

Pages Range: 1605-1620

Journal Issue: 10

DOI: 10.1093/ecco-jcc/jjab112

Abstract

Inflammatory bowel disease is a chronic disease with variable degrees of extent, severity, and activity. A proportion of patients will have disease that is refractory to licensed therapies, resulting in significant impairment in quality of life. The treatment of these patients involves a systematic approach by the entire multidisciplinary team, with particular consideration given to medical options including unlicensed therapies, surgical interventions, and dietetic and psychological support. The purpose of this review is to guide clinicians through this process and provide an accurate summary of the available evidence for different strategies.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Raine, T., Verstockt, B., Kopylov, U., Karmiris, K., Goldberg, R., Atreya, R.,... Cullen, G. (2021). ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohns & Colitis, 15(10), 1605-1620. https://dx.doi.org/10.1093/ecco-jcc/jjab112

MLA:

Raine, Tim, et al. "ECCO Topical Review: Refractory Inflammatory Bowel Disease." Journal of Crohns & Colitis 15.10 (2021): 1605-1620.

BibTeX: Download